Expansion of Elkton, Virginia Manufacturing Facility to Further Increase Merck’s HPV Vaccine Supply and Support Broader and Equitable Access

SourceYahoo Finance
Date Published04/04/2022
Author NameBusinesswire
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Merck
Parent companyMerck KGaA
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):150
Year reshoring announced:2022
City reshored to:Elkton
State(s) reshored to:VA
If relevant, work nearshored to:-
Product(s) reshoredhpv vaccine
What domestic positive factors made reshoring more attractive?Higher productivity, Manufacturing/engineering joint innovation (R&D), Proximity to customers/market
Find Reshoring Articles